Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mitoxantrone-related acute leukemia in MS: An open or closed book?
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Santhera and NIH collaborate to evaluate Catena® in primary progressive multiple sclerosis
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Myelin in cartilaginous fish.
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.
Genzyme Announces EMA Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription.
Immune competence after alemtuzumab treatment of multiple sclerosis.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci.
Teriflunomide for multiple sclerosis.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.

Pages